Evangelos ANDREAKOS;Maria SALAGIANNI;BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS
发明人:
Evangelos ANDREAKOS,Maria SALAGIANNI
申请号：
US16604378
公开号：
US20200157167A1
申请日:
2018.03.16
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to the field of treatment or prevention of obesity-related disorders, atherosclerosis or a coagulation disorder. In particular, the present invention relates to the use of an activator of IFNλ receptor for the treatment or prevention of such disorders or conditions, and corresponding methods of treatment.
